Skip to main content
. 2023 Aug 8;10(8):ENEURO.0204-23.2023. doi: 10.1523/ENEURO.0204-23.2023

Table 5.

Marker protein immunoreactivity in the 4 intersectional subsets

L2/3 L4 L5 L6 All layers
Calb2 (N = 3)
 CR+ % of all GFP+ 38.2 (3.7) 4.8 (4.8) 24.3 (3.7) 5.7 (1.8) 73.1 (4.6)
% in layer 69.3 88.9 83.2 55.9 73.1
 NPY+ % of all GFP+ 53.1 (2.0) 4.4 (1.5) 20.6 (6.5) 4.4 (1.5) 82.5 (8.6)
% in layer 83.4 76.5 83.5 75.0 82.5
 CB+ % of all GFP+ 31.3 (4.0) 7.1 (2.6) 20.7 (5.3) 2.4 (1.8) 61.5 (0.5)
% in layer 53.0 93.9 75.8 40.4 61.5
Chrna2 (N = 3)
 CR+ % of all GFP+ 0.4 (0.4) 1.0 (0.6) 1.4 (0.7)
% in layer 0.5 6.0 1.4
 NPY+ % of all GFP+ 0.0 (0.0) 4.3 (3.7) 5.1 (2.0) 9.4 (4.7)
% in layer 0.0 5.6 23.3 9.4
 CB+ % of all GFP+ 58.6 (4.7) 8.5 (1.2) 67.1 (3.7)
% in layer 67.4 64.9 67.1
Calb1 (N = 3)
 CR+ % of all GFP+ 11.7 (1.7) 1.9 (0.3) 4.8 (0.6) 0.8 (0.3) 19.2 (2.3)
% in layer 61.0 26.4 8.9 4.0 19.2
 NPY+ % of all GFP+ 15.3 (1.6) 2.9 (0.7) 10.4 (3.8) 9.4 (3.3) 38.0 (9.2)
% in layer 76.2 42.5 19.7 46.3 38.0
 CB+ % of all GFP+ 11.9 (2.8) 2.7 (0.6) 28.7 (4.2) 15.2 (1.8) 58.6 (5.6)
% in layer 62.9 37.4 55.9 67.9 58.6
Pdyn (N = 3)
 CR+ % of all GFP+ 6.6 (0.9) 1.4 (0.3) 4.4 (0.5) 0.5 (0.3) 13.0 (1.5)
% in layer 42.3 7.0 8.0 6.1 13.0
 NPY+ % of all GFP+ 6.3 (1.3) 5.3 (1.3) 6.7 (1.4) 5.2 (0.5) 23.5 (3.6)
% in layer 54.6 28.1 10.9 66.3 23.5
 CB+ % of all GFP+ 10.6 (2.3) 2.0 (0.4) 16.4 (0.7) 3.1 (0.4) 32.0 (2.0)
% in layer 60.6 8.7 31.1 41.6 32.0
All SOM
 CR+ (N = 12) % of all SOM 7.3 (0.6) 1.0 (0.2) 3.8 (0.3) 1.5 (0.1) 13.6 (0.9)
% in layer 51.5 9.0 7.4 6.4 13.6
 NPY+ (N = 12) % of all SOM 9.7 (1.0) 3.4 (0.6) 9.4 (1.4) 10.7 (0.9) 33.3 (3.0)
% in layer 71.4 30.6 18.7 43.3 33.3
 CB+ (N = 12) % of all SOM 7.9 (0.6) 1.7 (0.2) 20.0 (0.9) 10.3 (0.6) 39.9 (1.4)
% in layer 51.6 13.8 40.5 44.5 39.9

For each antibody, the top row indicates the count of immunostained cells in each layer, expressed as a percentage of all GFP+ cells in the same sections. The SEM is indicated in parenthesis. The bottom row expresses the same counts as a percentage of all GFP+ cells in the same layer. Empty cells indicate that no GFP+ neurons were found. N = 3 mice for each antibody in each genotype; most brains were used for 2–3 antibodies each. The bottom block in the table indicates counts of immunostained cells expressed as a percentage of all SOM cells (GFP+ and tdTomato+) counted in each brain, averaged over all genotypes, N = 12 mice/antibody. These data are plotted in Figure 6.